Incyte concludes $1.672 billion share buyback

Incyte concludes $1.672 billion share buyback - Investing.com

Incyte has agreed to buy back 27,866,666 of these shares at the stated price, amounting to roughly $1.672 billion, not including related fees ...

Incyte Announces Final Results of Tender Offer

Incyte has accepted for purchase 27,866,666 shares of its common stock at a purchase price of $60.00 per share, for a total cost of approximately $1.672 billion ...

Incyte Announces Intention to Buy Back up to $2.0 Billion of its ...

The Company has commenced a modified “Dutch Auction” tender offer to repurchase shares of its common stock for an aggregate purchase price of up to $1.672 ...

Incyte Announces Preliminary Results of Tender Offer

As such, the Company expects to repurchase a total of approximately 33.3 million shares of its common stock through the tender offer and the stock purchase ...

Incyte Completes $1.672 Billion Share Repurchase Program - What ...

... Incyte Corporation's Conclusion of $1.672 Billion Share Buyback Program. Incyte Concludes $1.672 Billion Share Repurchase. Incyte Corporation recently ...

Incyte Announces Intention to Buy Back up to $2.0 Billion of its ...

The Company has commenced a modified "Dutch Auction" tender offer to repurchase shares of its common stock for an aggregate purchase price of up ...

Incyte Announces Final Results of Tender Offer - SEC.gov

Based on the final count by Computershare Trust Company, N.A., the depositary for the tender offer, a total of 29,821,563 shares of Incyte's common stock were ...

Incyte Stock Jumps on 'Dutch Auction' Buyback Plan. How It Works.

Biopharmaceutical company Incyte is offering to buy up to $1.672 billion worth of its stock via a Dutch auction. It is also buying up to ...

Incyte (INCY) Announces Preliminary Results of Tender Offer

Incyte Corporation (Nasdaq: INCY) (“Incyte” or the “Company”) announced today the preliminary results of its modified “Dutch auction” tender ...

Novartis initiates new USD 15 billion share buyback highlighting ...

Basel, December 16, 2021 — Novartis today announced that it will initiate a share buyback of up to USD 15 billion to be executed by the end of 2023. The buyback ...

SEC Fillings 02 - Barchart Market Data Solutions - Barchart Demo Site

Eli Lilly and Company/Incyte ... stock options, were $1.672 billion during 2021, ... share repurchase program to repurchase up to $1.5 billion of our Common Stock.